Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and optimization of 3-bromo-N’-(4-hydroxybenzylidene)-4-methylbenzohydrazide derivatives as mTOR inhibitors that induce autophagic cell death and apoptosis in triple-negative breast cancer
Tian Xu, Jifa Zhang, Chengcan Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 219, pp. 113424-113424
Closed Access | Times Cited: 13

Showing 13 citing articles:

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 89
Overview of Research into mTOR Inhibitors
Beibei Mao, Qi Zhang, Li Ma, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5295-5295
Open Access | Times Cited: 71
Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer
Junhao Wu, Jing Ye, Qiang Xie, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 2989-3001
Closed Access | Times Cited: 43
Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy
Junping Pei, Xiaoli Pan, Aoxue Wang, et al.
Chemical Communications (2021) Vol. 57, Iss. 97, pp. 13194-13197
Closed Access | Times Cited: 53
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 6
Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy
Jifa Zhang, Pan Tang, Ling Zou, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 18025-18053
Open Access | Times Cited: 28
Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer
Rajibul Islam, Khor Poh Yen, Nur Najihah Izzati Mat Rani, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117877-117877
Open Access | Times Cited: 3
Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells
Subashani Maniam, Sandra Maniam
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9722-9722
Open Access | Times Cited: 22
Current scenario of pyrazole hybrids with anti‐breast cancer therapeutic applications
Mengyu Ma
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access
Insight into Structure-Activity Relationship of New Compounds for Breast Cancer Treatment
Lu Li, Qiangsheng Zhang
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 25, pp. 2373-2393
Closed Access | Times Cited: 1
Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free–Wilson Analysis for Improved In Vivo Efficacy
Sean T. Murphy, Joy Atienza, Jason W. Brown, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1544-1550
Open Access | Times Cited: 1
mTOR Signaling Pathways
Jianling Xie, Christopher G. Proud
Springer eBooks (2021), pp. 1010-1016
Closed Access
mTOR Signaling Pathways
Jianling Xie, Christopher G. Proud
Springer eBooks (2021), pp. 1-7
Closed Access
Page 1

Scroll to top